 | • レポートコード：QY20ST-08063 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の神経筋遮断薬（NMBA）市場について種類別（脱分極、非脱分極）、用途別（ Hospital Clinic Pharmacy Others ）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・神経筋遮断薬（NMBA）市場の概要 ・世界の主要地域別神経筋遮断薬（NMBA）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の神経筋遮断薬（NMBA）市場規模2015-2026：種類別（脱分極、非脱分極） ・世界の神経筋遮断薬（NMBA）市場規模2015-2026：用途別（ Hospital Clinic Pharmacy Others ） ・神経筋遮断薬（NMBA）の北米市場規模2015-2020 ・神経筋遮断薬（NMBA）のヨーロッパ市場規模2015-2020 ・神経筋遮断薬（NMBA）の中国市場規模2015-2020 ・神経筋遮断薬（NMBA）の日本市場規模2015-2020 ・神経筋遮断薬（NMBA）の東南アジア市場規模2015-2020 ・神経筋遮断薬（NMBA）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・神経筋遮断薬（NMBA）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・神経筋遮断薬（NMBA）の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Neuromuscular Blocking Agent (NMBA) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Neuromuscular Blocking Agent (NMBA) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Neuromuscular Blocking Agent (NMBA) industry.
Based on our recent survey, we have several different scenarios about the Neuromuscular Blocking Agent (NMBA) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Neuromuscular Blocking Agent (NMBA) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Neuromuscular Blocking Agent (NMBA) Scope and Market Size
The global Neuromuscular Blocking Agent (NMBA) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuromuscular Blocking Agent (NMBA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Neuromuscular Blocking Agent (NMBA) market is segmented into
Depolarizing
Non-depolarizing
Segment by Application, the Neuromuscular Blocking Agent (NMBA) market is segmented into
Hospital
Clinic
Pharmacy
Others
The Neuromuscular Blocking Agent (NMBA) market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuromuscular Blocking Agent (NMBA) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neuromuscular Blocking Agent (NMBA) Market Share Analysis
Neuromuscular Blocking Agent (NMBA) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuromuscular Blocking Agent (NMBA) business, the date to enter into the Neuromuscular Blocking Agent (NMBA) market, Neuromuscular Blocking Agent (NMBA) product introduction, recent developments, etc.
The major vendors covered:
AbbVie
GlaxoSmithKline
Pfizer
Hengrui Pharmaceutical
Abbott Laboratories
Fresenius Kabi
Sandoz
Somerset Therapeutics
Guike Pharmaceutical
Shanghai Pharmaceuticals
Themis Medicare
Nanjing King-Friend
1 Neuromuscular Blocking Agent (NMBA) Market Overview
1.1 Neuromuscular Blocking Agent (NMBA) Product Scope
1.2 Neuromuscular Blocking Agent (NMBA) Segment by Type
1.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Type (2020-2026)
1.2.2 Depolarizing
1.2.3 Non-depolarizing
1.3 Neuromuscular Blocking Agent (NMBA) Segment by Application
1.3.1 Global Neuromuscular Blocking Agent (NMBA) Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Neuromuscular Blocking Agent (NMBA) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Neuromuscular Blocking Agent (NMBA) Sales Growth Rate (2015-2026)
1.4.2 Global Neuromuscular Blocking Agent (NMBA) Revenue and Growth Rate (2015-2026)
1.4.3 Global Neuromuscular Blocking Agent (NMBA) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Neuromuscular Blocking Agent (NMBA) Industry Impact
1.5.1 How the Covid-19 is Affecting the Neuromuscular Blocking Agent (NMBA) Industry
1.5.1.1 Neuromuscular Blocking Agent (NMBA) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Neuromuscular Blocking Agent (NMBA) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Neuromuscular Blocking Agent (NMBA) Players to Combat Covid-19 Impact
2 Neuromuscular Blocking Agent (NMBA) Estimate and Forecast by Region
2.1 Global Neuromuscular Blocking Agent (NMBA) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Neuromuscular Blocking Agent (NMBA) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2015-2020)
2.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region (2015-2020)
2.3 Global Neuromuscular Blocking Agent (NMBA) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Neuromuscular Blocking Agent (NMBA) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Neuromuscular Blocking Agent (NMBA) Estimates and Projections (2015-2026)
2.4.2 Europe Neuromuscular Blocking Agent (NMBA) Estimates and Projections (2015-2026)
2.4.3 China Neuromuscular Blocking Agent (NMBA) Estimates and Projections (2015-2026)
2.4.4 Japan Neuromuscular Blocking Agent (NMBA) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Neuromuscular Blocking Agent (NMBA) Estimates and Projections (2015-2026)
2.4.6 India Neuromuscular Blocking Agent (NMBA) Estimates and Projections (2015-2026)
3 Global Neuromuscular Blocking Agent (NMBA) Competition Landscape by Players
3.1 Global Top Neuromuscular Blocking Agent (NMBA) Players by Sales (2015-2020)
3.2 Global Top Neuromuscular Blocking Agent (NMBA) Players by Revenue (2015-2020)
3.3 Global Neuromuscular Blocking Agent (NMBA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromuscular Blocking Agent (NMBA) as of 2019)
3.4 Global Neuromuscular Blocking Agent (NMBA) Average Price by Company (2015-2020)
3.5 Manufacturers Neuromuscular Blocking Agent (NMBA) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Neuromuscular Blocking Agent (NMBA) Players (Opinion Leaders)
4 Global Neuromuscular Blocking Agent (NMBA) Market Size by Type
4.1 Global Neuromuscular Blocking Agent (NMBA) Historic Market Review by Type (2015-2020)
4.1.1 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
4.1.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2015-2020)
4.1.3 Global Neuromuscular Blocking Agent (NMBA) Price by Type (2014-2020)
4.2 Global Neuromuscular Blocking Agent (NMBA) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Type (2021-2026)
4.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Type (2021-2026)
4.2.3 Global Neuromuscular Blocking Agent (NMBA) Price Forecast by Type (2021-2026)
5 Global Neuromuscular Blocking Agent (NMBA) Market Size by Application
5.1 Global Neuromuscular Blocking Agent (NMBA) Historic Market Review by Application (2015-2020)
5.1.1 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
5.1.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2015-2020)
5.1.3 Global Neuromuscular Blocking Agent (NMBA) Price by Application (2015-2020)
5.2 Global Neuromuscular Blocking Agent (NMBA) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Application (2021-2026)
5.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Application (2021-2026)
5.2.3 Global Neuromuscular Blocking Agent (NMBA) Price Forecast by Application (2021-2026)
3 North America Neuromuscular Blocking Agent (NMBA) Market Facts & Figures
3.2 North America Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
3.3 North America Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
3.4 North America Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
4 Europe Neuromuscular Blocking Agent (NMBA) Market Facts & Figures
4.2 Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
4.3 Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
4.4 Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
5 China Neuromuscular Blocking Agent (NMBA) Market Facts & Figures
5.2 China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
5.3 China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
5.4 China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
6 Japan Neuromuscular Blocking Agent (NMBA) Market Facts & Figures
6.2 Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
6.3 Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
6.4 Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
7 Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Facts & Figures
7.2 Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
8 India Neuromuscular Blocking Agent (NMBA) Market Facts & Figures
8.2 India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
8.3 India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
8.4 India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Neuromuscular Blocking Agent (NMBA) Business
12.1 AbbVie
12.1.1 AbbVie Neuromuscular Blocking Agent (NMBA) Corporation Information
12.1.2 AbbVie Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.1.3 AbbVie Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Neuromuscular Blocking Agent (NMBA) Products Offered
12.1.5 AbbVie Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Corporation Information
12.2.2 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.2.3 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Pfizer
12.3.1 Pfizer Neuromuscular Blocking Agent (NMBA) Corporation Information
12.3.2 Pfizer Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.3.3 Pfizer Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Neuromuscular Blocking Agent (NMBA) Products Offered
12.3.5 Pfizer Recent Development
12.4 Hengrui Pharmaceutical
12.4.1 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Corporation Information
12.4.2 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.4.3 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Products Offered
12.4.5 Hengrui Pharmaceutical Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Corporation Information
12.5.2 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.5.3 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Products Offered
12.5.5 Abbott Laboratories Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Corporation Information
12.6.2 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.6.3 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 Sandoz
12.7.1 Sandoz Neuromuscular Blocking Agent (NMBA) Corporation Information
12.7.2 Sandoz Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.7.3 Sandoz Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sandoz Neuromuscular Blocking Agent (NMBA) Products Offered
12.7.5 Sandoz Recent Development
12.8 Somerset Therapeutics
12.8.1 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Corporation Information
12.8.2 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.8.3 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Products Offered
12.8.5 Somerset Therapeutics Recent Development
12.9 Guike Pharmaceutical
12.9.1 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Corporation Information
12.9.2 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.9.3 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Products Offered
12.9.5 Guike Pharmaceutical Recent Development
12.10 Shanghai Pharmaceuticals
12.10.1 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Corporation Information
12.10.2 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.10.3 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Products Offered
12.10.5 Shanghai Pharmaceuticals Recent Development
12.11 Themis Medicare
12.11.1 Themis Medicare Neuromuscular Blocking Agent (NMBA) Corporation Information
12.11.2 Themis Medicare Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.11.3 Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Themis Medicare Neuromuscular Blocking Agent (NMBA) Products Offered
12.11.5 Themis Medicare Recent Development
12.12 Nanjing King-Friend
12.12.1 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Corporation Information
12.12.2 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Business Overview and Total Revenue
12.12.3 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Products Offered
12.12.5 Nanjing King-Friend Recent Development
13 Neuromuscular Blocking Agent (NMBA) Manufacturing Cost Analysis
13.1 Neuromuscular Blocking Agent (NMBA) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neuromuscular Blocking Agent (NMBA)
13.4 Neuromuscular Blocking Agent (NMBA) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neuromuscular Blocking Agent (NMBA) Distributors List
14.3 Neuromuscular Blocking Agent (NMBA) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Neuromuscular Blocking Agent (NMBA) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Neuromuscular Blocking Agent (NMBA) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Neuromuscular Blocking Agent (NMBA) Players to Combat Covid-19 Impact
Table 8. Global Market Neuromuscular Blocking Agent (NMBA) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) by Region (2015-2020)
Table 10. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2015-2020)
Table 11. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Region (2015-2020)
Table 13. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Neuromuscular Blocking Agent (NMBA) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Neuromuscular Blocking Agent (NMBA) (MT) of Key Companies (2015-2020)
Table 18. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Company (2015-2020)
Table 19. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Company (2015-2020)
Table 21. Global Neuromuscular Blocking Agent (NMBA) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromuscular Blocking Agent (NMBA) as of 2019)
Table 22. Global Neuromuscular Blocking Agent (NMBA) Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Neuromuscular Blocking Agent (NMBA) Manufacturing Sites and Area Served
Table 24. Manufacturers Neuromuscular Blocking Agent (NMBA) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Neuromuscular Blocking Agent (NMBA) Players
Table 27. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 28. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Type (2015-2020)
Table 29. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Neuromuscular Blocking Agent (NMBA) Price (MT) by Type (2015-2020)
Table 31. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Type (2021-2026)
Table 32. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Type (2021-2026)
Table 34. Global Neuromuscular Blocking Agent (NMBA) Price (MT) by Type (2021-2026)
Table 35. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) by Application (2015-2020)
Table 36. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Application (2015-2020)
Table 37. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Neuromuscular Blocking Agent (NMBA) Price (MT) by Application (2015-2020)
Table 39. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) by Application (2021-2026)
Table 40. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Application (2021-2026)
Table 41. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Application (2021-2026)
Table 43. Global Neuromuscular Blocking Agent (NMBA) Price (MT) by Application (2021-2026)
Table 44. United States Neuromuscular Blocking Agent (NMBA) Sales (MT) by Company (2015-2020)
Table 45. United States Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
Table 46. United States Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 47. United States Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
Table 48. United States Neuromuscular Blocking Agent (NMBA) Sales (MT) by Application (2015-2020)
Table 49. United States Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
Table 50. Europe Neuromuscular Blocking Agent (NMBA) Sales (MT) by Company (2015-2020)
Table 51. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
Table 52. Europe Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 53. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
Table 54. Europe Neuromuscular Blocking Agent (NMBA) Sales (MT) by Application (2015-2020)
Table 55. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
Table 56. China Neuromuscular Blocking Agent (NMBA) Sales (MT) by Company (2015-2020)
Table 57. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
Table 58. China Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 59. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
Table 60. China Neuromuscular Blocking Agent (NMBA) Sales (MT) by Application (2015-2020)
Table 61. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
Table 62. Japan Neuromuscular Blocking Agent (NMBA) Sales (MT) by Company (2015-2020)
Table 63. Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
Table 64. Japan Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 65. Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
Table 66. Japan Neuromuscular Blocking Agent (NMBA) Sales (MT) by Application (2015-2020)
Table 67. Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
Table 74. India Neuromuscular Blocking Agent (NMBA) Sales (MT) by Company (2015-2020)
Table 75. India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company (2015-2020)
Table 76. India Neuromuscular Blocking Agent (NMBA) Sales (MT) by Type (2015-2020)
Table 77. India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2015-2020)
Table 78. India Neuromuscular Blocking Agent (NMBA) Sales (MT) by Application (2015-2020)
Table 79. India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2015-2020)
Table 80. AbbVie Corporation Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. AbbVie Neuromuscular Blocking Agent (NMBA) Product
Table 84. AbbVie Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer Neuromuscular Blocking Agent (NMBA) Product
Table 94. Pfizer Recent Development
Table 95. Hengrui Pharmaceutical Corporation Information
Table 96. Hengrui Pharmaceutical Description and Business Overview
Table 97. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product
Table 99. Hengrui Pharmaceutical Recent Development
Table 100. Abbott Laboratories Corporation Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product
Table 104. Abbott Laboratories Recent Development
Table 105. Fresenius Kabi Corporation Information
Table 106. Fresenius Kabi Description and Business Overview
Table 107. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product
Table 109. Fresenius Kabi Recent Development
Table 110. Sandoz Corporation Information
Table 111. Sandoz Description and Business Overview
Table 112. Sandoz Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Sandoz Neuromuscular Blocking Agent (NMBA) Product
Table 114. Sandoz Recent Development
Table 115. Somerset Therapeutics Corporation Information
Table 116. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Somerset Therapeutics Description and Business Overview
Table 118. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product
Table 119. Somerset Therapeutics Recent Development
Table 120. Guike Pharmaceutical Corporation Information
Table 121. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Guike Pharmaceutical Description and Business Overview
Table 123. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product
Table 124. Guike Pharmaceutical Recent Development
Table 125. Shanghai Pharmaceuticals Corporation Information
Table 126. Shanghai Pharmaceuticals Description and Business Overview
Table 127. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product
Table 129. Shanghai Pharmaceuticals Recent Development
Table 130. Themis Medicare Corporation Information
Table 131. Themis Medicare Description and Business Overview
Table 132. Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Themis Medicare Neuromuscular Blocking Agent (NMBA) Product
Table 134. Themis Medicare Recent Development
Table . Nanjing King-Friend Corporation Information
Table . Nanjing King-Friend Description and Business Overview
Table . Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product
Table . Nanjing King-Friend Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Neuromuscular Blocking Agent (NMBA) Distributors List
Table 143. Neuromuscular Blocking Agent (NMBA) Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuromuscular Blocking Agent (NMBA) Product Picture
Figure 2. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neuromuscular Blocking Agent (NMBA) Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Pharmacy Examples
Figure 9. Others Examples
Figure 10. Global Neuromuscular Blocking Agent (NMBA) Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Neuromuscular Blocking Agent (NMBA) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Neuromuscular Blocking Agent (NMBA) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Neuromuscular Blocking Agent (NMBA) Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Neuromuscular Blocking Agent (NMBA) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Neuromuscular Blocking Agent (NMBA) Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Neuromuscular Blocking Agent (NMBA) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Neuromuscular Blocking Agent (NMBA) Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Neuromuscular Blocking Agent (NMBA) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Neuromuscular Blocking Agent (NMBA) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Neuromuscular Blocking Agent (NMBA) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Neuromuscular Blocking Agent (NMBA) Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Neuromuscular Blocking Agent (NMBA) Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Neuromuscular Blocking Agent (NMBA) Players Market Share by Revenue in Neuromuscular Blocking Agent (NMBA) 2015 & 2019
Figure 28. Neuromuscular Blocking Agent (NMBA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Type (2015-2020)
Figure 30. Global Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Application (2015-2020)
Figure 32. Global Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2019
Figure 34. United States Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2019
Figure 35. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company in 2019
Figure 36. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2019
Figure 37. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application in 2019
Figure 38. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company in 2019
Figure 39. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2019
Figure 40. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application in 2019
Figure 41. Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company in 2019
Figure 42. Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2019
Figure 43. Japan Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application in 2019
Figure 44. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company in 2019
Figure 45. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2019
Figure 46. Southeast Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application in 2019
Figure 47. India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Company in 2019
Figure 48. India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type in 2019
Figure 49. India Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application in 2019
Figure 50. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Hengrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Somerset Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Guike Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Shanghai Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Themis Medicare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Nanjing King-Friend Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Neuromuscular Blocking Agent (NMBA)
Figure 64. Manufacturing Process Analysis of Neuromuscular Blocking Agent (NMBA)
Figure 65. Neuromuscular Blocking Agent (NMBA) Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
神経筋伝達モニターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Neuromuscular Transmission Monitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuromuscu…- 神経筋電気刺激（NMES / EMS）デバイスの世界市場レポート2020 A recently published report by QY Research titled Global Neuromuscular Electrical Stimulation (NMES/EMS) Devices Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report…
- 水遮断化合物の世界市場レポート2020 A recently published report by QY Research titled Global Water Blocking Compounds Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- 神経筋刺激装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Neuromuscular Stimulators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuromuscular Stimu…
- 処方青色光遮断メガネの世界市場レポート2020 A recently published report by QY Research titled Global Prescription Blue Light Blocking Glasses Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistic…